Induction of fibrinolytic activity in HeLa cells by phorbol myristate acetate. Tissue-type plasminogen activator antigen and mRNA augmentation require intermediate protein biosynthesis.
E K Waller , W D Schleuning
Journal of Biological Chemistry 260 ( 10) 6354 -6360
70
1985
Lipid formulations of amphotericin B preserve and stabilize renal function in HSCT recipients.
C B Miller , E K Waller , H G Klingemann , M C Dignani
Bone Marrow Transplantation 33 ( 5) 543 -548
21
2004
Favorable impact of pre-transplant ATG on outcomes of reduced-intensity hematopoietic cell transplants from partially mismatched unrelated donors.
A A Langston , J M Prichard , S Muppidi , A Nooka
Bone Marrow Transplantation 49 ( 2) 185 -189
12
2014
Risk associations between HLA-DPB1 T-cell epitope matching and outcome of unrelated hematopoietic cell transplantation are independent of HLA-DPA1
K Fleischhauer , M A Fernandez-Viña , T Wang , M Haagenson
Bone Marrow Transplantation 49 ( 9) 1176 -1183
23
2014
Biomarkers of immune activation to screen for severe, acute GVHD.
K J August , K-Y Chiang , R M Bostick , W D Flanders
Bone Marrow Transplantation 46 ( 4) 601 -604
36
2011
Palifermin for the reduction of acute GVHD: a randomized, double-blind, placebo-controlled trial.
M H Jagasia , R Abonour , G D Long , B J Bolwell
Bone Marrow Transplantation 47 ( 10) 1350 -1355
15
2012
Long-term progression-free survival after early autologous transplantation for mantle-cell lymphoma
S Murali , E Winton , E K Waller , L T Heffner
Bone Marrow Transplantation 42 ( 8) 529 -534
15
2008
Eosinophilic pulmonary syndrome as a manifestation of GVHD following hematopoietic stem cell transplantation in three patients
M Akhtari , A A Langston , E K Waller , A A Gal
Bone Marrow Transplantation 43 ( 2) 155 -158
10
2009
Complex-formation and inhibition of urokinase by blood plasma proteins.
E K Waller , W D Schleuning , E Reich
Biochemical Journal 215 ( 1) 123 -131
33
1983
Isolation and characterization of the human tissue-type plasminogen activator structural gene including its 5' flanking region.
R Fisher , E K Waller , G Grossi , D Thompson
Journal of Biological Chemistry 260 ( 20) 11223 -11230
124
1985
Ph+ ALL patients in first complete remission have similar survival after reduced intensity and myeloablative allogeneic transplantation: impact of tyrosine kinase inhibitor and minimal residual disease
Veronika Bachanova , David I Marks , Mei-Jie Zhang , Hailin Wang
Leukemia 28 ( 3) 658 -665
124
2014
Rapid recovery from panobinostat (LBH589)-induced thrombocytopenia in mice involves a rebound effect of bone marrow megakaryocytes
C R Giver , D L Jaye , E K Waller , J L Kaufman
Leukemia 25 ( 2) 362 -365
29
2011
Radiation leukemia virus-induced thymic lymphomas express a restricted repertoire of T-cell receptor V beta gene products.
A Sen-Majumdar , I L Weissman , G Hansteen , J Marian
Journal of Virology 68 ( 2) 1165 -1172
8
1994
Tuberculosis in umbilical cord blood transplant recipients: clinical characteristics and challenges
J Zhang , M Mosunjac , A Moon , A Nooka
Bone Marrow Transplantation 50 ( 3) 465 -468
2
2015
Low blood lymphocyte count at 30 days post transplant predicts worse acute GVHD and survival but not relapse in a large retrospective cohort.
Z Gul , E Van Meter , M Abidi , I Ditah
Bone Marrow Transplantation 50 ( 3) 432 -437
6
2015
Clinically significant adverse events after major ABO mismatch BMT.
R S Nickel , E K Waller , M Qayed , K-Y Chiang
Bone Marrow Transplantation 51 ( 1) 148 -149
2
2016
Monitoring the kinetics of B-cell recovery following rituximab may guide the management of steroid-refractory chronic GvHD
Z DeFilipp , M Purcell , W A C Harris , D J Chandra
Bone Marrow Transplantation 51 ( 4) 607 -609
2016
Plasmacytoid dendritic cells in allogeneic hematopoietic cell transplantation: benefit or burden?
J J Auletta , S M Devine , E K Waller
Bone Marrow Transplantation 51 ( 3) 333 -343
14
2016
Comparable outcomes following two or three cycles of high-dose chemotherapy and autologous stem cell transplantation for patients with relapsed/refractory germ cell tumors
Z DeFilipp , C B Rosand , D A Goldstein , V A Master
Bone Marrow Transplantation 52 ( 1) 132 -134
2017
Impact of early CMV reactivation in cord blood stem cell recipients in the current era
M Ramanathan , , P Teira , M Battiwalla
Bone Marrow Transplantation 51 ( 8) 1113 -1120
24
2016